Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published Announced figure as of 31 October 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Due to declining demand for the ADC portfolio, a difference arose between the new supply plan and the minimum purchase obligations to the CMO. A loss compensation amount of approximately ¥75.7 billion will be recorded as a one-off expense in fiscal 2025. In addition, an estimated loss of approximately ¥19.3 billion, comprising impairment losses and compensation payments associated with the cancellation and termination of the related contracts, will be recorded following the cancellation of the ADC-related capital investment projects at the Odawara Plant.
In the non-consolidated results, a special loss of ¥149.4 billion is expected to be recorded, primarily for the reasons described above. In the consolidated results, the items include a provision of approximately ¥75.7 billion for loss compensation payable to the CMO and approximately ¥19.3 billion in impairment losses and compensation payments related to ADC-related equipment at the Odawara Plant.
| Item | Details |
|---|---|
| Net Sales | ¥2,100,000 million → ¥2,123,000 million（+1.1%） |
| Operating profit | ¥335,000 million → ¥229,000 million（-31.6%） |
| Profit attributable to owners of the parent | ¥288,000 million → ¥260,000 million（-9.7%） |
| Net income per share | 155.59 yen and sen → 140.51 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | Announced figure as of 31 October 2025 |
| Previous-period results | Fiscal 2024: revenue of ¥1,886,256 million, core operating profit of ¥312,835 million, operating profit of ¥331,925 million, profit before tax of ¥355,631 million, profit for the year of ¥295,756 million, profit for the year attributable to owners of the parent of ¥295,756 million, and basic earnings per share of ¥155.96 |
| Reason for the revision | Due to declining demand for the ADC portfolio, a difference arose between the new supply plan and the minimum purchase obligations to the CMO. A loss compensation amount of approximately ¥75.7 billion will be recorded as a one-off expense in fiscal 2025. In addition, an estimated loss of approximately ¥19.3 billion, comprising impairment losses and compensation payments associated with the cancellation and termination of the related contracts, will be recorded following the cancellation of the ADC-related capital investment projects at the Odawara Plant. |
| Details and amount of extraordinary loss | In the non-consolidated results, a special loss of ¥149.4 billion is expected to be recorded, primarily for the reasons described above. In the consolidated results, the items include a provision of approximately ¥75.7 billion for loss compensation payable to the CMO and approximately ¥19.3 billion in impairment losses and compensation payments related to ADC-related equipment at the Odawara Plant. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Demand declined following a review of the target patient population and launch plan based on the clinical trial results for the ADC portfolio, resulting in a difference between the minimum purchase obligations to the CMO under the former and revised supply plans. Accordingly, a provision will be recorded for the loss compensation amount. In addition, the ADC-related capital investment projects at the Odawara Plant will be cancelled due to the revision of the supply plan, and the estimated losses comprising impairment losses and compensation payments associated with the cancellation and termination of the related contracts will be recorded.